| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
466 |
| issn |
1546-1696
1087-0156 |
| issueIdentifier |
6 |
| pageRange |
465-466 |
| publicationName |
Nature Biotechnology |
| startingPage |
465 |
| bibliographicCitation |
Sheridan C. First cystic fibrosis drug advances towards approval. Nat Biotechnol. 2011 Jun 07;29(6):465–6. doi: 10.1038/nbt0611-465. PMID: 21654649. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3846b5f33e58c49c9df14ea28c1477d |
| date |
2011-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/21654649
https://doi.org/10.1038/nbt0611-465 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20305
https://portal.issn.org/resource/ISSN/1546-1696
https://portal.issn.org/resource/ISSN/1087-0156 |
| language |
English |
| source |
https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
First cystic fibrosis drug advances towards approval |
| discusses |
http://id.nlm.nih.gov/mesh/M0028383
http://id.nlm.nih.gov/mesh/M0448397
http://id.nlm.nih.gov/mesh/M0541284
http://id.nlm.nih.gov/mesh/M0001333
http://id.nlm.nih.gov/mesh/M0023650
http://id.nlm.nih.gov/mesh/M0000958
http://id.nlm.nih.gov/mesh/M0491218 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D015363Q000494
http://id.nlm.nih.gov/mesh/D003550Q000188
http://id.nlm.nih.gov/mesh/D000627Q000494
http://id.nlm.nih.gov/mesh/D017277 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D004345
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D010597Q000379
http://id.nlm.nih.gov/mesh/D000893Q000627
http://id.nlm.nih.gov/mesh/D000627Q000627
http://id.nlm.nih.gov/mesh/D003001
http://id.nlm.nih.gov/mesh/D019005Q000235
http://id.nlm.nih.gov/mesh/D017326
http://id.nlm.nih.gov/mesh/D000900Q000627
http://id.nlm.nih.gov/mesh/D015363Q000627
http://id.nlm.nih.gov/mesh/D019005Q000378 |